Caplin Point Lab

{
  "main_header": {
    "sid": 640544,
    "name": "Caplin Point Lab",
    "stock_name": "Caplin Point Lab",
    "full_name": "Caplin Point Laboratories Ltd",
    "name_url": "stocks-analysis/caplin-point-lab",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "2,575.05",
    "chg": -9.5,
    "chgp": "-0.37%",
    "dir": -1,
    "prev_price": "2,584.55",
    "mcapval": "19,499.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 524742,
    "symbol": "CAPLIPOINT",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE475E01026",
    "curr_date": "Aug 07, 03:30 PM",
    "curr_time": "21:02 PM",
    "last_traded_at": "Aug 07, 03:30 PM IST",
    "bse_nse_vol": "46.33 k",
    "exc_status": "Active",
    "traded_date": "Aug 07, 2026",
    "traded_date_str": "2026 08 07",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/caplin-point-lab-640544-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Caplin Point Laboratories Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/caplin-point-laboratories-ltd-is-rated-buy-4142789",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/CaplinPointLabo_mojoScore_4142789.png",
        "date": "2026-08-08 10:10:28",
        "description": "Caplin Point Laboratories Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 27 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 August 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Caplin Point Laboratories Gains 2.03%: 2 Key Factors Driving the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/caplin-point-laboratories-gains-203-2-key-factors-driving-the-week-4131810",
        "imagepath": "",
        "date": "2026-08-01 16:08:59",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>27 Jul:</strong> Intraday high surge to Rs.2,638.95 (+7.48%)</p>\n                    <p><strong>28 Jul:</strong> Upgrade to Buy rating by MarketsMOJO</p>\n                    <p><strong>31 Jul:</strong> Week closes at Rs.2,514.70 (+2.03% weekly)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.2,464.65</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.2,514.70</div><div class=\"stat-change positive\">+2.03%</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">We..."
      },
      {
        "title": "When is the next results date for Caplin Point Laboratories Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-caplin-point-laboratories-ltd-4129216",
        "imagepath": "",
        "date": "2026-07-30 23:17:06",
        "description": "The next results date for Caplin Point Laboratories Ltd is scheduled for 12 August 2026...."
      },
      {
        "title": "Caplin Point Laboratories Ltd Upgraded to Buy on Strong Technical and Financial Performance",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/caplin-point-laboratories-ltd-upgraded-to-buy-on-strong-technical-and-financial-performance-4123644",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/CaplinPointLabo_mojoScore_4123644.png",
        "date": "2026-07-28 08:40:16",
        "description": "Caplin Point Laboratories Ltd has been upgraded from a Hold to a Buy rating, reflecting significant improvements across technical indicators, financial trends, valuation metrics, and overall quality. This upgrade, effective from 27 Jul 2026, highlights the company’s robust quarterly performance, bullish technical signals, and sustained shareholder returns, positioning it favourably within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Caplin Point Laboratories Ltd Surges 7.48% to Day's High of Rs 2638.95 — Outperforms Sector by 5.42 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/caplin-point-laboratories-ltd-hits-intraday-high-with-748-surge-on-27-jul-2026-4122789",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/CaplinPointLabo_priceRelatedfactors_4122789.png",
        "date": "2026-07-27 14:47:32",
        "description": "The Sensex advanced 1.03% on 27 Jul 2026, yet Caplin Point Laboratories Ltd outpaced the broader market with a robust 7.48% gain, reaching an intraday high of Rs 2638.95. This 5.42-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific rally rather than a market-wide lift."
      },
      {
        "title": "Caplin Point Laboratories Declines 5.71%: Mixed Technical Signals Shape Weekly Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/caplin-point-laboratories-declines-571-mixed-technical-signals-shape-weekly-performance-4120933",
        "imagepath": "",
        "date": "2026-07-26 09:01:54",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>20 Jul:</strong> Stock opens strong at Rs.2,647.75 (+1.29%) despite flat Sensex</p>\n                    <p><strong>22 Jul:</strong> Mojo Grade downgraded to Hold amid mixed technical and valuation signals</p>\n                    <p><strong>23 Jul:</strong> Technical momentum shifts to bullish despite 4.84% price drop</p>\n                    <p><strong>24 Jul:</strong> Week closes at Rs.2,464.65, down 0.90% on the day</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.2,614.00</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Wee..."
      },
      {
        "title": "Caplin Point Laboratories Ltd Technical Momentum Shifts Amid Mixed Indicators",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/caplin-point-laboratories-ltd-technical-momentum-shifts-amid-mixed-indicators-4116996",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/CaplinPointLabo_technicaldot_4116996.png",
        "date": "2026-07-23 08:02:36",
        "description": "Caplin Point Laboratories Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish to a bullish trend despite a recent decline in price. The stock’s technical indicators present a complex picture, with bullish signals from MACD and moving averages contrasting with bearish cues from the monthly RSI and KST. This article analyses these technical parameters in detail, placing the stock’s performance in context with broader market movements and its historical returns."
      },
      {
        "title": "Caplin Point Laboratories Downgraded to Hold Amid Mixed Technical and Valuation Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/caplin-point-laboratories-downgraded-to-hold-amid-mixed-technical-and-valuation-signals-4114644",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/CaplinPointLabo_mojoScore_4114644.png",
        "date": "2026-07-22 08:22:42",
        "description": "Caplin Point Laboratories Ltd, a notable player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 21 July 2026. This adjustment reflects a nuanced reassessment across four key parameters: Quality, Valuation, Financial Trend, and Technicals. Despite strong financial performance and consistent returns, evolving technical indicators and valuation concerns have tempered the outlook, prompting a more cautious stance among investors."
      },
      {
        "title": "Caplin Point Laboratories Ltd Sees Technical Momentum Shift Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/caplin-point-laboratories-ltd-sees-technical-momentum-shift-amid-mixed-indicator-signals-4114403",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/CaplinPointLabo_technicaldot_4114403.png",
        "date": "2026-07-22 08:01:52",
        "description": "Caplin Point Laboratories Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, transitioning from a bullish to a mildly bullish trend. Despite a recent downgrade in its Mojo Grade from Buy to Hold, the stock continues to demonstrate resilience with mixed signals from key technical indicators such as MACD, RSI, and moving averages, reflecting a complex market sentiment."
      }
    ],
    "total": 666,
    "sid": "640544",
    "stock_news_url": "https://www.marketsmojo.com/news/caplin-point-laboratories-640544"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "30-Jul-2026",
      "details": "Post-results conference call invite for the quarter ended June 30 2026 is enclosed herewith.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Approval Of Financial Results And Recommendation Of Final Dividend If Any.",
      "datetime": "29-Jul-2026",
      "details": "Caplin Point Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve 1. Unaudited financial results of the Company for the Quarter ended June 30 2026 (both Standalone & Consolidated) 2. recommendation of Final Dividend if any for the FY 2025-26 and fixation of record date for this purpose.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "11-Jul-2026",
      "details": "Intimation pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulation 2018 for the quarter ended June 30 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "12 Aug 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Caplin Point Laboratories Ltd has declared <strong>200%</strong> dividend, ex-date: 29 May 26",
          "dt": "2026-05-29",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Caplin Point Laboratories Ltd has announced <strong>2:10</strong> stock split, ex-date: 19 Oct 16",
          "dt": "2016-10-19",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Caplin Point Laboratories Ltd is Rated Buy

2026-08-08 10:10:28

Caplin Point Laboratories Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 27 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 August 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Caplin Point Laboratories Gains 2.03%: 2 Key Factors Driving the Week

2026-08-01 16:08:59

Key Events This Week

27 Jul: Intraday high surge to Rs.2,638.95 (+7.48%)

28 Jul: Upgrade to Buy rating by MarketsMOJO

31 Jul: Week closes at Rs.2,514.70 (+2.03% weekly)

Week Open

Rs.2,464.65

Week Close

Rs.2,514.70

+2.03%

We...

Read full news article

When is the next results date for Caplin Point Laboratories Ltd?

2026-07-30 23:17:06

The next results date for Caplin Point Laboratories Ltd is scheduled for 12 August 2026....

Read full news article

Caplin Point Laboratories Ltd Upgraded to Buy on Strong Technical and Financial Performance

2026-07-28 08:40:16

Caplin Point Laboratories Ltd has been upgraded from a Hold to a Buy rating, reflecting significant improvements across technical indicators, financial trends, valuation metrics, and overall quality. This upgrade, effective from 27 Jul 2026, highlights the company’s robust quarterly performance, bullish technical signals, and sustained shareholder returns, positioning it favourably within the Pharmaceuticals & Biotechnology sector.

Read full news article

Caplin Point Laboratories Ltd Surges 7.48% to Day's High of Rs 2638.95 — Outperforms Sector by 5.42 Percentage Points

2026-07-27 14:47:32

The Sensex advanced 1.03% on 27 Jul 2026, yet Caplin Point Laboratories Ltd outpaced the broader market with a robust 7.48% gain, reaching an intraday high of Rs 2638.95. This 5.42-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific rally rather than a market-wide lift.

Read full news article

Caplin Point Laboratories Declines 5.71%: Mixed Technical Signals Shape Weekly Performance

2026-07-26 09:01:54

Key Events This Week

20 Jul: Stock opens strong at Rs.2,647.75 (+1.29%) despite flat Sensex

22 Jul: Mojo Grade downgraded to Hold amid mixed technical and valuation signals

23 Jul: Technical momentum shifts to bullish despite 4.84% price drop

24 Jul: Week closes at Rs.2,464.65, down 0.90% on the day

Week Open

Rs.2,614.00

Wee...

Read full news article

Caplin Point Laboratories Ltd Technical Momentum Shifts Amid Mixed Indicators

2026-07-23 08:02:36

Caplin Point Laboratories Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish to a bullish trend despite a recent decline in price. The stock’s technical indicators present a complex picture, with bullish signals from MACD and moving averages contrasting with bearish cues from the monthly RSI and KST. This article analyses these technical parameters in detail, placing the stock’s performance in context with broader market movements and its historical returns.

Read full news article

Caplin Point Laboratories Downgraded to Hold Amid Mixed Technical and Valuation Signals

2026-07-22 08:22:42

Caplin Point Laboratories Ltd, a notable player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 21 July 2026. This adjustment reflects a nuanced reassessment across four key parameters: Quality, Valuation, Financial Trend, and Technicals. Despite strong financial performance and consistent returns, evolving technical indicators and valuation concerns have tempered the outlook, prompting a more cautious stance among investors.

Read full news article

Caplin Point Laboratories Ltd Sees Technical Momentum Shift Amid Mixed Indicator Signals

2026-07-22 08:01:52

Caplin Point Laboratories Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, transitioning from a bullish to a mildly bullish trend. Despite a recent downgrade in its Mojo Grade from Buy to Hold, the stock continues to demonstrate resilience with mixed signals from key technical indicators such as MACD, RSI, and moving averages, reflecting a complex market sentiment.

Read full news article

View All News